Evercore ISI Group Maintains In-Line on Guardant Health, Raises Price Target to $95
Guardant Health
Guardant Health GH | 0.00 |
Evercore ISI Group analyst Daniel Markowitz maintains Guardant Health (NASDAQ:
GH) with a In-Line and raises the price target from $90 to $95.